Advancements in therapeutic paradigm: Harnessing IL‐17A inhibitor secukinumab to ameliorate psoriasis vulgaris in the presence of resistant pericardial effusion

Affiliations

Qing Tan: Department of Rheumatology Second Affiliated Hospital Guangzhou Medical University Guangzhou Guangdong China
Lifeng Xu: Department of Cardiology Second Affiliated Hospital Guangzhou Medical University Guangzhou Guangdong China
Ruoxi Wu: The Second Clinical Medical School Guangzhou Medical University Guangzhou Guangdong China
Zeying Lin: Department of Rheumatology Second Affiliated Hospital Guangzhou Medical University Guangzhou Guangdong China
Wenhui Huang: Department of Rheumatology Second Affiliated Hospital Guangzhou Medical University Guangzhou Guangdong China
Shuilian Yu: Department of Rheumatology Second Affiliated Hospital Guangzhou Medical University Guangzhou Guangdong China

Abstract

No abstracts available.

ISSN: 2767-1410 (Print); 2767-1429 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy; Medicine: Internal medicine: Specialties of internal medicine: Diseases of the musculoskeletal system
Website: https://onlinelibrary.wiley.com/journal/27671429